Categories: Market Watch

GBB Drink Labs Initiates $53 Million Lawsuit Against FSD Biosciences Inc. For Trade Secret Misappropriation

Miami, FL, December 5, 2023 — GBB Drink Labs, a leader in innovative beverage solutions, has officially filed a lawsuit against FSD Biosciences Inc. in response to the blatant non-compliance with a Cease-and-Desist letter issued on April 14th, 2023. The lawsuit, formally submitted on May 1st, 2023, in the U.S. District Court for the Southern District of Florida, seeks $53 million in damages for a material breach of a mutual nondisclosure agreement and trade secret misappropriation.

The legal action stems from seven months of collaborative discussions between GBB Drink Labs and FSD Pharma, exploring a business opportunity related to GBB’s groundbreaking blood alcohol detoxification drink. FSD Pharma’s public disclosure of the misappropriation of GBB’s trade secrets, without crucial information, during the launch of a new research and development program has led to the initiation of legal proceedings.

The lawsuit alleges that FSD Pharma not only misused GBB’s proprietary and confidential material to attract capital and renowned entrepreneurs but also artificially inflated the price of FSD Pharma’s publicly traded stock. GBB Drink Labs, responding strongly to these actions, is seeking compensatory and punitive damages, coupled with an injunction to prevent any further unlawful disclosure and use of GBB’s trade secrets.

The case, officially titled GBB DRINK LAB, INC. v. FSD BIOSCIENCES INC., has been assigned case number 0:23-cv-60800-AHS in the U.S. District Court for the Southern District of Florida.

For more information on the case, please visit www.sinkingstocks.com.

About GBB Drink Labs: GBB Drink Labs boasts a patented formula that accelerates the process of converting alcohol to sugar in the body, facilitating rapid blood alcohol detoxification. The company has dedicated years to developing a proprietary drink, culminating in a successful acquisition of its patents by Jupiter Wellness, Inc. The closing date for the acquisition is set for August 11th, 2023, with Jupiter Wellness proudly introducing the world’s first rapid blood alcohol detoxification product, “Safety Shot.”

Information contained on this page is provided by an independent third-party content provider. eTrendystock make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please email at contact@etrendystock.com

BTW

Recent Posts

SEC Bolsters Crypto Enforcement With Cyber and Emerging Technologies Unit

The U.S. Securities and Exchange Commission is significantly ramping up its efforts to police emerging…

1 day ago

Orava Opens Early Access To Orava SAFE For Qatar Top 40 Startups at Web Summit

Singapore, 21st February 2025, ZEX PR WIRE, Orava Pte Ltd is a fintech company accelerating…

2 days ago

Canary Capital Launches Axelar Trust: Details

Canary Capital announced the launch of the Canary AXL Trust, a private investment vehicle offering…

2 days ago

Nigeria Sues Binance for $81.5 Billion Over Economic Damage and Tax Evasion

Nigeria has filed a landmark lawsuit against Binance, demanding $79.5 billion in economic damages and…

3 days ago

Binance US Brings Back USD Deposits and Withdrawals After Two-Year Hiatus

After a two-year hiatus, Binance US, the American arm of the leading cryptocurrency exchange, has…

3 days ago

Gold Tokenization: Hong Kong Doubles Down on Tokenized Commodities

Hong Kong is forging ahead with its ambition to become a global hub for virtual…

4 days ago